BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
3.410
-0.050 (-1.45%)
Mar 28, 2024, 2:56 PM EDT - Market open

BioAtla Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
111.47215.51244.98238.613.710.86
Cash & Cash Equivalents
111.47215.51244.98238.613.710.86
Cash Growth
-48.27%-12.03%2.67%6341.82%-65.90%-
Other Current Assets
4.944.922.312.080.81.8
Total Current Assets
116.41220.43247.29240.684.5112.66
Property, Plant & Equipment
3.15.156.984.14.683.88
Other Long-Term Assets
0.150.150.150.150.150.1
Total Long-Term Assets
3.255.317.134.264.833.98
Total Assets
119.66225.74254.42244.949.3416.64
Accounts Payable
26.7221.6118.4212.0711.978.69
Deferred Revenue
00021.8222.422.46
Current Debt
1.621.521.3909.710
Other Current Liabilities
000-1.63-17.38-1.96
Total Current Liabilities
28.3423.1319.8132.2626.729.2
Long-Term Debt
0.842.463.980.688.4115
Other Long-Term Liabilities
19.8119.8119.812.0230.2220.89
Total Long-Term Liabilities
20.6422.2723.792.738.6335.89
Total Liabilities
48.9945.443.634.9665.3545.08
Total Debt
2.463.985.370.6818.1215
Debt Growth
-38.21%-25.88%687.54%-96.24%20.80%-
Retained Earnings
-416.26-292.8-186.32-90.92-148.35-118.56
Shareholders' Equity
70.67180.34210.82209.97-55.96-28.47
Net Cash / Debt
109.01211.53239.61237.92-14.42-4.14
Net Cash / Debt Growth
-48.46%-11.72%0.71%---
Net Cash Per Share
2.285.436.9328.23-0.26-0.08
Working Capital
88.06197.3227.48208.42-22.213.47
Book Value Per Share
1.484.636.1024.91-1.02-0.52
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).